Factors Influencing International Normalized Ratio in Patients Anticoagulated With Warfarin(Special Issue in Hornor of the Retirement of Professor Makoto Iwata at the Department of Neurology, Tokyo Women's Medical University)

Abstract

Preventive effect of warfarin for the development of cardiogenic embolism is well established. However, variability in the required dose for each individual makes it difficult to prescribe adequate dose of warfarin because of the potential risk of hemorrhage. In the present study, we retrospectively evaluated relationship between the international normalized ratio (INR) and several patient-specific clinical factors such as gender, age, body weight, patient's medical status, risk factors for stroke, renal/liver function, and hemostatic markers. Eighty-six patients (55: men, 31: women, mean age of 68 years) anticoagulated with oral warfarin between April 2004 and March 2006 were entered in the study. Among patient-specific factors, we analysed factors influencing INR during warfarin therapy. Under warfarin treatment, three factors were associated with increased INR/mg ratio; body weight<40 kg, coagulopathy, and renal failure. In contrast, following factors decreased INR/mg ratio; age < 50 years, body weight &ge;80 kg, and increased levels of platelet activation markers

Similar works

Full text

thumbnail-image

Tokyo Women’s Medical University-Information &amp; Knowledge Database

redirect
Last time updated on 29/08/2013

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.